Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

M-TAPA Versus Erector Spinae Plane Block for Postoperative Analgesia in Upper Abdominal Surgery: A Prospective Randomized Controlled Trial

NCT07926256 is registered in ClinicalTrials.gov with Beni-Suef University as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07926256 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
M-TAPA Versus Erector Spinae Plane Block for Postoperative Analgesia in Upper Abdominal Surgery: A Prospective Randomized Controlled Trial
Lead sponsor
Beni-Suef University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 30, 2026
Completion date
December 30, 2027
Enrollment
66 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain management

Arms

As registered; 2 arms.

  • Modified External Oblique Intercostal Plane Block Active comparatorM-TAPA block

    Using a high-frequency linear probe placed vertically over the costal margin at the 9th-10th ribs. 20 ml of Bupivacaine 0.25% will be injected on each side into the plane between the perichondrium and the transversus abdominis muscle.

  • Erector Spinae Plane Block group Active comparatorErector Spinae Plane Block

    Using a high-frequency linear probe in a longitudinal orientation 2.5-3 cm lateral to the T7 spinous process. 20 ml of Bupivacaine 0.25% will be injected on each side into the plane deep to the erector spinae muscle and superficial to the transverse process.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Total morphine consumption during the first 24 hours postoperative

Lead sponsor's other trials

Beni-Suef University, most recent start first.

Similar trials

Same condition (Agnosia) and phase, most recent start first.